Arteris Director Sells $100K in Stock

Raman Chitkara, a director at semiconductor IP firm Arteris, offloaded 5,000 shares worth over $100,000.

Apr. 17, 2026 at 10:34am

An extreme close-up of complex, industrial-looking semiconductor manufacturing equipment and circuitry, conveying the technical sophistication behind the company's products.An insider's view of the intricate machinery powering Arteris' semiconductor IP innovations.Santa Clara Today

Arteris, Inc. (NASDAQ:AIP) Director Raman Chitkara sold 5,000 shares of the company's stock on April 14th, 2026 at an average price of $20.05 per share, resulting in a total transaction of $100,250. Following the sale, Chitkara still directly owns 152,867 shares in the company, valued at over $3 million.

Why it matters

Insider transactions, such as stock sales by company directors, can provide insights into management's views on the company's prospects and valuation. This sale by Arteris director Raman Chitkara represents a 3.17% decrease in his ownership stake, which may signal his belief that the stock is fairly valued or overvalued at current levels.

The details

Chitkara's sale of 5,000 Arteris shares was disclosed in a filing with the SEC. The shares were sold at an average price of $20.05, generating total proceeds of $100,250. After the sale, Chitkara continues to hold 152,867 shares in the company, valued at over $3 million based on the current stock price.

  • The stock sale occurred on Tuesday, April 14th, 2026.

The players

Raman Chitkara

A director at Arteris, Inc., a fabless semiconductor intellectual property company.

Arteris, Inc.

A fabless semiconductor intellectual property company that specializes in on-chip interconnect solutions and system IP for advanced integrated circuits.

Got photos? Submit your photos here. ›

The takeaway

This insider transaction by an Arteris director provides a data point on management's perspective on the company's valuation, though it does not necessarily indicate a broader trend. Investors should consider this sale in the context of the company's overall financial performance and outlook.